The Bill Gates Foundation and CSIR will work together to find ways to begin partnerships in science and technology. These will concentrate on the production and testing of new preventions, treatments and strategies that can help resolve major health problems affecting India and other developing countries. According to the MoU, genetic diseases impacting infant and neonatal mortality, modern diagnostics and devices for infectious diseases and environmental surveillance, the production of cost-effective drug processes, vaccinations, biologics and diagnostics developing novel, microbiome-directed foods, and the socio-economic effects of science technological tools and other areas of health and development will be areas of research.
On behalf of the Bill & Melinda Gates Foundation and Dr G N Dayananda, Head, Technology Management Directorate-Industry Interface, CSIR, the MoU was signed by Hari Menon, Director, India Country Office. Talking about the importance of this collaboration, Hari Menon stated, “Under this MOU, we look forward to collaborating with CSIR on many important themes linked to India’s health and development priorities. We are excited about the innovation potential of CSIR’s wide network and the promise of our partnership to develop innovative tools and solutions for public health challenges in India and globally.”
On the occasion of the signing of the MoU, DG-CSIR, Dr Shekhar C Mande, commented ‘The opportunity to work closely with Gates Foundation on broad spectrum of activities in health and development, will accelerate the R&D and implementation of innovations in the coming years that are not only relevant to India but to the world’.